Somerville, MA, United States of America

Daniel Philip O'Connell

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Somerville, MA (US) (2013 - 2015)
  • Boston, MA (US) (2015)

Company Filing History:


Years Active: 2013-2015

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Philip O'Connell

Introduction

Daniel Philip O'Connell is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on niacin mimetics. With a total of three patents to his name, O'Connell's inventions are aimed at addressing various therapeutic indications in mammals.

Latest Patents

O'Connell's latest patents include groundbreaking discoveries in the realm of niacin mimetics. One of his patents discloses 6-(morpholinoalkyl)-substituted pyridines, along with their pharmaceutically acceptable salts and prodrugs. These compounds are designed to be active against a range of mammalian therapeutic indications. Another patent focuses on heterocyclylalkyl-substituted and heteroaralkyl-substituted pyridines, which also demonstrate activity against various therapeutic conditions in mammals.

Career Highlights

Throughout his career, O'Connell has worked with esteemed institutions such as Tufts College and Arisaph Pharmaceuticals, Inc. His work in these organizations has allowed him to further develop his innovative ideas and contribute to the advancement of pharmaceutical science.

Collaborations

O'Connell has collaborated with notable colleagues, including William W Bachovchin and Hung-sen Lai. These partnerships have played a crucial role in enhancing his research and expanding the impact of his inventions.

Conclusion

Daniel Philip O'Connell is a distinguished inventor whose work on niacin mimetics has the potential to significantly influence therapeutic practices. His contributions to the field of pharmaceuticals are noteworthy and reflect his commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…